IRIDEX Corp
NASDAQ:IRIX
IRIDEX Corp
Accounts Receivables
IRIDEX Corp
Accounts Receivables Peer Comparison
Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IRIDEX Corp
NASDAQ:IRIX
|
Accounts Receivables
$6.5m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Receivables
$2.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Receivables
$2.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Accounts Receivables
$3.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Receivables
$6.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Receivables
$1.1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
See Also
What is IRIDEX Corp's Accounts Receivables?
Accounts Receivables
6.5m
USD
Based on the financial report for Mar 30, 2024, IRIDEX Corp's Accounts Receivables amounts to 6.5m USD.
What is IRIDEX Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
0%
Over the last year, the Accounts Receivables growth was -6%. The average annual Accounts Receivables growth rates for IRIDEX Corp have been -7% over the past three years , -5% over the past five years .